Maiva Pharma, an injectables Contract Development and Manufacturing Organisation (CDMO), has secured Rs 1,000 crores in both primary and secondary financing from a fund managed by Morgan Stanley Private Equity Asia and India Life Sciences Fund - IV (InvAscent).
![[Funding alert] Maiva Pharma Secures INR 1000 Cr From Morgan Stanley Private Equity, InvAscent](https://img-cdn.publive.online/fit-in/580x348/filters:format(webp)/viestories/media/post_attachments/wp-content/uploads/2024/05/Funding-alert-Maiva-Pharma-Secures-INR-1000-Cr-FromMorgan-Stanley-Private-Equity-InvAscen.webp)